Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Biofrontera Inc
BFRICurrent price
0.88 USD
0 USD (0.00%)
Last closed
0.88 USD
Company
www.biofrontera.us.com
ISIN
US09077D1000
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Capitalization
6 042 437 USD
Yield for 12 month
-78.80 %
1Y
3Y
5Y
10Y
15Y
BFRI
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts. Address: 120 Presidential Way, Woburn, MA, United States, 01801
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
11.5 USDP/E ratio
–Dividend Yield
–Current Year
+34 071 000 USD
Last Year
+28 674 000 USD
Current Quarter
+7 839 000 USD
Last Quarter
+7 901 000 USD
Current Year
+15 563 000 USD
Last Year
+13 489 000 USD
Current Quarter
+3 388 000 USD
Last Quarter
+3 955 000 USD
Key Figures BFRI
1 year
3 years
5 years
10 years
EBITDA
-18 316 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-40.24 %
PEG Ratio
–
Return On Equity TTM
-149.41 %
Wall Street Target Price
11.5 USD
Revenue TTM
35 241 000 USD
Book Value
2.14 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
34 %
Dividend Yield
–
Gross Profit TTM
13 489 000 USD
Earnings per share
-2.74 USD
Diluted Eps TTM
-2.74 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-38.34 %
Dividend Analytics BFRI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BFRI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
05.07.2023
Dividend Date
–
Stock Valuation BFRI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.0878
Price Sales TTM
0.1715
Enterprise Value EBITDA
-0.792
Price Book MRQ
0.5538
Financials BFRI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BFRI
For 52 weeks
0.61 USD
4.39 USD
50 Day MA
1.07 USD
Shares Short Prior Month
200 639
200 Day MA
1.19 USD
Short Ratio
0.82
Shares Short
473 763
Short Percent
8.56 %
BeatStart